Additional file 1 of An economic evaluation of cabazitaxel versus a second androgen receptor-targeted agent (ARTA) for patients with metastatic castration-resistant prostate cancer previously treated with docetaxel and an ARTA: the United States payer perspective

Authors :: Morgans, Alicia K.
Hutson, Thomas
Guan, Alice Kai Dan
Garcia, David
Zhou, Anna
Drea, Edward
Vogelzang, Nicholas J.
Publication Year :: 2022
Publisher :: figshare, 2022.
Abstract: Additional file 1.

Full Text Access

Tools